Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites

Phase 2

Completed

• Conditions: Cirrhosis; Ascites

• Registration Number: NCT00115947
• Lead Sponsor: Hvidovre University Hospital

Brief Summary

The purpose of this study is to investigate the effect of terlipressin on myocardial perfusion and renal function.

Hypothesis: Significant improvement of renal function reflected by: glomerular filtration rate (GFR), renal blood flow (RBF), excretion of salt and metabolites in the urine and related hormones and peptides in the blood. No effect on the systolic function of the heart.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-12
• Status Verified: 2005-06
• Study First Submitted: 2005-06-26
• Study First Submitted QC: 2005-06-26
• Study First Posted: 2005-06-27
• Study Completion: 2006-01
• Last Update Submitted: 2006-03-08
• Last Update Posted: 2006-03-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Cirrhosis and ascites

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Trial Locations

Locations (1)

Hvidovre Hospital; 🇩🇰 Copenhagen, Hvidovre, Denmark